• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    C

    Carolinas Pain Institute

    EST. 2004
    222论文总数
    4,930引用总数

    论文量&引用量时间轴

    机构学者

    论文(222)

    年份
    起
    –
    止
    排序
    1Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain: 12-Month Results from the COMFORT-randomized Controlled Trial
    John Hatheway, Alexander Hersel,Mitchell Engle,Genaro Gutierrez, Vishal Khemlani,Leonardo Kapural,Gregory Moore, Reginald Ajakwe,Drew Trainor,Jennifer Hah,Peter S Staats,James Makous,

    BackgroundThere is paucity of data from randomized controlled trials supporting the use of peripheral nerve stimulation, a well-established therapy for the treatment of chronic pain. This study was undertaken, in part, to provide randomized controlled trial data in support of patient access to appropriate peripheral nerve stimulation therapy. The COMFORT study is the first large, postmarket, multicenter randomized controlled trials investigating the use of a Food and Drug Administration-cleared micro-implantable pulse generator (IPG) for treating chronic pain via peripheral nerve stimulation therapy.MethodsConsented, eligible subjects were randomized to either the active arm, which received peripheral nerve stimulation and conventional medical management, or the control arm, which received conventional medical management alone and were allowed to cross over to the active arm, after 3 months. Pain and patient-reported outcomes were captured. Therapy responders were subjects who achieved at least a 50% reduction in pain scores compared with baseline. We are reporting the 12-month results of this 36-month study.ResultsAt 12 months, the responder rate was 87% with a 69% average reduction in pain compared with baseline (7.5±1.2 to 2.3±1.7; p<0.001). Statistical significance was achieved for all patient-reported outcomes. There was an excellent safety profile with no serious adverse device effects or reports of pocket pain. A majority of subjects used unique programming options and found this device easy to use and comfortable to wear.ConclusionsThese 12-month results are consistent with previously reported 6-month outcomes from this study, showing durability of peripheral nerve stimulation treatment with the micro-IPG system; subjects realized sustained large reduction in pain and improvement in patient-reported outcomes following treatment with this micro-IPG system.Trial registration numberNCT05287373.

    2026Regional anesthesia and pain medicine(2026)引用:6
    引用
    AI阅读
    加入学术空间
    2Cooled Radiofrequency Ablation Provides Extended Clinical Utility in the Management of Chronic Sacroiliac Joint Pain: 12-Month Follow-Up Results from the Observational Phase of a Randomized, Multicenter, Comparative-Effectiveness Crossover Study
    Steven Paul Cohen,Leonardo Kapural,Lynn Kohan,Sean Li, Robert Hurley, Richard Vallejo,Yashar Eshraghi, Pradeep Dinakar,Shravani Durbhakula,Douglas P Beall,Mehul J Desai,David Reece,

    INTRODUCTION:Sacroiliac joint (SIJ) pain comprises up to 30% of cases of mechanical low back pain (LBP), the leading cause of disability worldwide. Despite sacral lateral branch cooled radiofrequency ablation (CRFA) showing efficacy in clinical trials, there is a lack of comparative-effectiveness long-term follow-up. METHODS:In this randomized, multicenter, comparative-effectiveness study, 210 patients with injection-confirmed SIJ pain who responded to prognostic lateral branch blocks were randomly assigned to receive CRFA of the L5 dorsal ramus and S1-S3/4 lateral branches or standard medical management (SMM) consisting of pharmacotherapy, physical therapy, injections, and integrative therapies. Patients were followed up at 1, 3, 6, 9, and 12 months, with participants reporting unsatisfactory SMM outcomes being allowed to crossover (XO) and receive CRFA at 3 months. The primary outcome measure was the mean change in average LBP score on a 0-10 Numeric Rating Scale (NRS), with secondary outcomes including measures of quality of life (QoL) and function. A responder was defined as a participant who experienced a ≥30% or ≥2-point decrease in average daily NRS pain score coupled with a score ≥5 out of 7 (moderately better) on the Patient Global Impression of Change scale. RESULTS:At 12 months, the mean NRS pain score declined from a baseline of 6.4±1.4 to 3.5±2.6, with 57.4% (35/61) of participants in the randomized CRFA cohort experiencing a ≥2-point or 30% decrease in average LBP from baseline. In the crossover cohort, 35/63 (55.6%) subjects had the same experience 12 months following the XO procedure; in the XO group, the mean LBP decreased from 6.1±1.5 to 3.4±2.5. Patients also experienced clinically meaningful improvements in QoL via EuroQoL-5D-5L at 12 months (mean change of +0.22±0.27 in the originally-treated CRFA group and +0.21±0.33 in the XO group). Oswestry Disability Index (ODI) scores also improved by 12.4%±14.7 (CRFA) and 13.7%±17.1 (XO) from baseline at study-end. No serious adverse events related to the CRFA procedure were reported. CONCLUSION:CRFA in patients with SIJ pain provided clinically significant and sustained improvements for 12 months following a single CRFA treatment, regardless of previous SMM treatment. TRIAL REGISTRATION NUMBER:NCT03601949.

    2026Regional anesthesia and pain medicine(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3ID# 2201244 REMOTE SPINAL CORD STIMULATION MANAGEMENT REDUCES PATIENT BURDENS AND IMPROVES CARE: 12-MONTH STUDY RESULTS
    Marc Russo, James Yu,Kasra Amirdelfan,Leonardo Kapural,Paul Verrills
    2026Neuromodulation Technology at the Neural Interface(2026)
    引用
    AI阅读
    加入学术空间
    4Closed-loop SCS and Sensing: Now and in the Future
    Krishnan Chakravarthy, Vwaire Orhurhu, Jan Willem Kallewaard, Leonardo Kapural, Alaa Abd-Elsayed, Yashar Eshraghi, Lakshmi Rekha Narra, Priyanka Ghosh, Samir Sheth, David W Lee, Rajiv Reddy, Lisa M Johanek,

    BACKGROUND:Spinal cord stimulation (SCS) for chronic pain has undergone many advancements over the years, including the introduction of novel stimulation waveforms, expansion to treat new pain conditions, and the more recent implementation of evoked compound action potential (ECAP) controlled, closed-loop (CL) SCS. The ECAP-a measure of neural activation-may be used as a biosignal for adjusting stimulation amplitudes to avoid under- and overstimulation associated with spinal cord movement relative to the SCS lead. CONTENT OVERVIEW:Using ECAPs in a CL system relies on successfully isolating the neural response signal from the relatively large stimulation artifact. A study with the first commercialized CL-SCS device investigated pain relief with low-frequency stimulation within a therapy window described as ranging from initial perception of sensation to discomfort (paresthesia window). In contrast, another commercial system with CL technology includes additional functionality to support consistent therapy with higher frequency stimulation set at or near the perception threshold. This more recently approved CL-SCS system leverages advanced artifact suppression and flexible CL control algorithms to afford dose control for conventional, high-frequency (up to 1200 Hz), and contemporary SCS waveforms. CONCLUSIONS:Here, we discuss the history and motivation for CL systems in SCS and the challenges faced when implementing such technology.

    2026Pain medicine (Malden, Mass)(2026)
    引用
    AI阅读
    加入学术空间
    5ID# 2201494 TEN-kHZ SPINAL CORD STIMULATION PROVIDES EFFECTIVE TREATMENT FOR NONSURGICAL BACK PAIN ACROSS PAIN TYPES, INCLUDING NOCICEPTIVE
    Aaron Calodney,Naresh Patel,Leonardo Kapural,Erika Petersen, Julie Pilitsis,Dawood Sayed, Rose Province-Azalde,Kerry Bradley
    2026Neuromodulation Technology at the Neural Interface(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 222 篇论文

    合作机构(100)

    阿肯色医科大学合作论文 21
    Evolve Restorative Center合作论文 18
    克利夫兰诊所合作论文 13
    加州大学旧金山分校合作论文 12
    Ainsworth Institute of Pain Management合作论文 12
    波士顿科学合作论文 12
    温纳贝戈医学中心合作论文 11
    佛罗里达大学合作论文 11
    杜克大学合作论文 10
    加利福尼亚大学圣地亚哥分校合作论文 10

    机构统计